Pathum Raksa Project: Addressing Disparity in Breast Cancer Care Through National Innovation in Thailand

References

• Anderson BO, Ilbawi AM, Fidarova E, et al. The Global Breast Cancer Initiative: a strategic collaboration to strengthen health care for non-communicable diseases. Lancet Oncol. 2021;22:578–581. doi:10.1016/S1470-2045(21)00071-133691141
   PubMed Web of Science ®Google Scholar
• Virani S, Bilheem S, Chansaard W, et al. National and subnational population-based incidence of cancer in Thailand: assessing cancers with the highest burdens. Cancers. 2017;9(12):108. doi:10.3390/cancers9080108
   PubMed Web of Science ®Google Scholar
• Parra-Herran C, Romero Y, Milner D. Pathology and Laboratory Medicine in cancer care: a global analysis of national cancer control plans. Int J Cancer. 2021;148:1938–1947. doi:10.1002/ijc.3338433152147
   PubMed Web of Science ®Google Scholar
• Anglade F, Milner DA, Brock JE. Can pathology diagnostic services for cancer be stratified and serve global health? Cancer. 2020;126(Suppl 10):2431–2438. doi:10.1002/cncr.3287232348564
   PubMed Web of Science ®Google Scholar
• Allison KH, Hammond MEH, Dowsett M, et al. Estrogen and progesterone receptor testing in breast cancer: American society of clinical oncology/College of American pathologists guideline update. Arch Pathol Lab Med. 2020;144:545–563. doi:10.5858/arpa.2019-0904-SA31928354
   PubMed Web of Science ®Google Scholar
• Globocan: Cancer Today. The Global Cancer Observatory. Thailand: International Agency for Research on Cancer (IARC), World Health Organization (WHO); 2020.
   Google Scholar
• Wattanasri N, Manoroma W, Viriyayudhagorn S. Laboratory accreditation in Thailand: a systemic approach. Am J Clin Pathol. 2010;134:534–540. doi:10.1309/AJCPZYY19WMKMAZT20855633
   PubMed Web of Science ®Google Scholar
• Sampatanukul P, Chaiwun B, Wongwaisayawan S, et al. A two-phase study model for the standardization of HER2 immunohistochemical assay on invasive ductal carcinoma of the breast. J Med Assoc Thai. 2005;88:1680–1688.16471119
   PubMedGoogle Scholar
• Metter DM, Colgan TJ, Leung ST, Timmons CF, Park JY. Trends in the US and Canadian pathologist workforces from 2007 to 2017. JAMA Netw Open. 2019;2:e194337. doi:10.1001/jamanetworkopen.2019.433731150073
   PubMed Web of Science ®Google Scholar
• Koonmee S, Sirithunyaporn S, Phanomsri E. Hormonal receptors status of breast cancer in Northeastern Thai women: an analysis of 241 cases at Srinagarind hospital. Srinagarind Med J. 2006;21:343–351.
   Google Scholar
• Deyarmin B, Kane JL, Valente AL, et al. Effect of ASCO/CAP guidelines for determining ER status on molecular subtype. Ann Surg Oncol. 2013;20:87–93. doi:10.1245/s10434-012-2588-822875649
   PubMed Web of Science ®Google Scholar
• Engstrom MJ, Opdahl S, Hagen AI, et al. Molecular subtypes, histopathological grade and survival in a historic cohort of breast cancer patients. Breast Cancer Res Treat. 2013;140:463–473. doi:10.1007/s10549-013-2647-223901018
   PubMed Web of Science ®Google Scholar
• Goldhirsch A, Ingle JN, Gelber RD, Coates AS, Thurlimann B, Senn HJ. Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009. Ann Oncol. 2009;20:1319–1329. doi:10.1093/annonc/mdp32219535820
   PubMed Web of Science ®Google Scholar
• Goldhirsch A, Winer EP, Coates AS, et al. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. Ann Oncol. 2013;24:2206–2223. doi:10.1093/annonc/mdt30323917950
   PubMed Web of Science ®Google Scholar
• Virani S, Chindaprasirt J, Wirasorn K, et al. Breast cancer incidence trends and projections in Northeastern Thailand. J Epidemiol. 2018;28:323–330. doi:10.2188/jea.JE2017004529760320
   PubMed Web of Science ®Google Scholar
• Nkoy FL, Hammond ME, Rees W, et al. Variable specimen handling affects hormone receptor test results in women with breast cancer: a large multihospital retrospective study. Arch Pathol Lab Med. 2010;134:606–612. doi:10.1043/1543-2165-134.4.60620367311
   PubMed Web of Science ®Google Scholar
• Schrodi S, Braun M, Andrulat A, et al. Outcome of breast cancer patients with low hormone receptor positivity: analysis of a 15-year population-based cohort. Ann Oncol. 2021;32(11):1410–1424. doi:10.1016/j.annonc.2021.08.198834419555
   PubMed Web of Science ®Google Scholar
• Chirappapha P, Sukarayothin T, Wasuthit Y, Suvikapalornkul R, Lertsithichai P, Kongdan Y. Disease-free probability and triple-negative breast cancer. Rama Med J. 2012;35:5–13. doi:10.33165/rmj.2012.35.1.117663
   Google Scholar
• Chottanapund S, Van Duursen MBM, Ratchaworapong K, Navasumrit P, Ruchirawat M, Van den Berg M. Androgen receptor expression in Thai breast cancer patients. Med Sci. 2016;4. doi:10.3390/medsci4030015
   Google Scholar
• Chuthapisith S, Permsapaya W, Warnnissorn M, Akewanlop C, Sirivatanauksorn V, Prasarttong Osoth P. Breast cancer subtypes identified by the ER, PR and HER-2 status in Thai women. Asian Pac J Cancer Prev. 2012;13:459–462. doi:10.7314/apjcp.2012.13.2.45922524806
   PubMedGoogle Scholar
• Laohavinij S, Paul V, Maneenil K. Survival and prognostic factors of metastatic breast cancer. J Med Assoc Thai. 2017;100(Suppl 1):S16–26.29927171
   PubMedGoogle Scholar
• Lertsanguansinchai P, Chottetanaprasith T, Chatamra K, et al. Estrogen and progesterone receptors status in Thai female breast cancer patients: an analysis of 399 cases at King Chulalongkorn Memorial Hospital. J Med Assoc Thai. 2002;85(Suppl 1):S193–202.12188412
   PubMedGoogle Scholar
• Sripan P, Sriplung H, Pongnikorn D, et al. Clinical subtypes of breast cancer in Thai women: a population-based study of Chiang Mai province. Asian Biomed. 2019;13:11–17. doi:10.1515/abm-2019-0034
   Web of Science ®Google Scholar
• Sujarittanakarn S, Himakhun W, Worasawate W, Prasert W. The case to case comparison of hormone receptors and HER2 status between primary breast cancer and synchronous axillary lymph node metastasis. Asian Pac J Cancer Prev. 2020;21:1559–1565. doi:10.31557/APJCP.2020.21.6.155932592349
   PubMedGoogle Scholar
• Virani S, Wetzel EC, Laohawiriyakamol S, et al. Ethnic disparity in breast cancer survival in southern Thai women. Cancer Epidemiol. 2018;54:82–89. doi:10.1016/j.canep.2018.02.00729684800
   PubMed Web of Science ®Google Scholar
• Hicks DG, Boyce BF. The challenge and importance of standardizing pre-analytical variables in surgical pathology specimens for clinical care and translational research. Biotech Histochem. 2012;87:14–17. doi:10.3109/10520295.2011.59183221732745
   PubMed Web of Science ®Google Scholar
• Hewitt SM, Lewis FA, Cao Y, et al. Tissue handling and specimen preparation in surgical pathology: issues concerning the recovery of nucleic acids from formalin-fixed, paraffin-embedded tissue. Arch Pathol Lab Med. 2008;132:1929–1935. doi:10.1043/1543-2165-132.12.192919061293
   PubMed Web of Science ®Google Scholar
• Costa RLB, Gradishar WJ. Triple-negative breast cancer: current practice and future directions. J Oncol Pract. 2017;13:301–303. doi:10.1200/JOP.2017.02333328489982
   PubMed Web of Science ®Google Scholar
• Lian CL, Li GQ, Zhou P, Wang J, He ZY, Wu SG. Triple-negative breast cancer outcomes: does AJCC 8th staging improve chemotherapy decision-making. Breast. 2021;59:117–123. doi:10.1016/j.breast.2021.06.00934229126
   PubMed Web of Science ®Google Scholar
• Llombart-Cussac A, Cortes J, Pare L, et al. HER2-enriched subtype as a predictor of pathological complete response following trastuzumab and lapatinib without chemotherapy in early-stage HER2-positive breast cancer (PAMELA): an open-label, single-group, multicentre, Phase 2 trial. Lancet Oncol. 2017;18:545–554. doi:10.1016/S1470-2045(17)30021-928238593
   PubMed Web of Science ®Google Scholar
• Acheampong T, Kehm RD, Terry MB, Argov EL, Tehranifar P. Incidence trends of breast cancer molecular subtypes by age and race/ethnicity in the US from 2010 to 2016. JAMA Netw Open. 2020;3:e2013226. doi:10.1001/jamanetworkopen.2020.1322632804214
   PubMed Web of Science ®Google Scholar